Role of apoptosis-inducing factor in perinatal hypoxic-ischemic brain injuryJuan Rodriguez, Tao Li, Yiran Xu, Yanyan Sun, Changlian Zhu205-213
Therapeutic potential of neuromodulation for demyelinating diseasesElliot H. Choi, Chioma Nwakalor, Nolan J. Brown, Joonho Lee, Michael Y. Oh, In Hong Yang214-217
Dysfunctional glia: contributors to neurodegenerative disordersMarta Sidoryk-W?grzynowicz, Lidia Stru?yńska218-222
Inflammation/bioenergetics-associated neurodegenerative pathologies and concomitant diseases: a role of mitochondria targeted catalase and xanthophyllsMikhail A. Filippov, Olga G. Tatarnikova, Natalia V. Pozdnyakova, Vasily V. Vorobyov223-233
Potential therapeutic effects of polyphenols in Parkinson's disease: in vivo and in vitro pre-clinical studiesClaudio Giuliano, Silvia Cerri, Fabio Blandini234-241
Possible implications of dysregulated nicotinic acetylcholine receptor diffusion and nanocluster formation in myasthenia gravisFrancisco J. Barrantes242-246
Hydrogel-based local drug delivery strategies for spinal cord repairRobert B. Shultz, Yinghui Zhong247-253
Altered physiology of gastrointestinal vagal afferents following neurotraumaEmily N. Blanke, Gregory M. Holmes, Emily M. Besecker254-263
Prospects for intelligent rehabilitation techniques to treat motor dysfunctionCong-Cong Huo, Ya Zheng, Wei-Wei Lu, Teng-Yu Zhang, Dai-Fa Wang, Dong-Sheng Xu, Zeng-Yong Li264-269
